Successful treatment of urgent bleeding in von Willebrand disease with factor VIII/VWF concentrate (Humate-P®): use of the ristocetin cofactor assay (VWF:RCo) to measure potency and to guide therapy-Reference-Cited by-同舟云学术

Successful treatment of urgent bleeding in von Willebrand disease with factor VIII/VWF concentrate (Humate-P®): use of the ristocetin cofactor assay (VWF:RCo) to measure potency and to guide therapy

Published:2003-11 Issue:6 Volume:9 Page:688-695
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:

Author:

Gill J. Cox,Ewenstein B. M.,Thompson A. R.,Mueller-Velten G.,Schwartz B. A.,

Publisher

Wiley

Subject

Genetics (clinical),Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1351-8216.2003.00816.x/fullpdf

Reference24 articles.

1. Insight into the structure, function, and biosynthesis of factor VIII through recombinant DNA technology;Kaufman;Ann Hematol,1991

2. Inactivation of human factor VIII by activated protein C-Cofactor activity of protein S and protective effect of von Willebrand factor;Koedam;J Clin Invest,1988

3. Factor VIII binds to von Willebrand factor via its Mr− 80,000 light chain;Hamer;Eur J Biochem,1987

4. The effect of thrombin on the complex between factor VIII and von Willebrand factor;Hamer;Eur J Biochem,1987

5. Hemophilia A - Medical Progress (Review);Hoyer;N Engl J Med,1994

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting von Willebrand disease: the current status and future directions of management therapies;Expert Review of Hematology;2023-10-12

2. Complications in children with ventricular assist devices: systematic review and meta-analyses;Heart Failure Reviews;2021-03-04

3. Hemostatic Agents and Blood Components Used to Stop Bleeding;Management of Bleeding Patients;2021

4. Evolution of replacement therapy for von Willebrand disease: From plasma fraction to recombinant von Willebrand factor;Blood Reviews;2019-11

5. Analysis of current perioperative management with Haemate®P/Humate P®in von Willebrand disease: Identifying the need for personalized treatment;Haemophilia;2018-03-24